The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Marvell Technology Group Ltd. (NASDAQ:MRVL) concerning whether a series of statements by Marvell Technology Group regarding its business, its prospects and its operations were materially false and misleading at the time they were made. Marvell Technology Group Ltd. (NASDAQ:MRVL) stock opened today at $16.31 and is currently trading at $16.34.The stock showed a negative weekly performance of -0.94%.
Analysts at BMO Capital Markets raised their price objective on shares of Apollo Group (NASDAQ:APOL) to $40.00 in a research report issued to clients and investors on Tuesday, Analyst Ratings News reports. BMO Capital Markets’ price objective would suggest a potential upside of 16.82% from the company’s current price. Apollo Education Group Inc (NASDAQ:APOL) stock opened at $34.38, in current trading session and currently is at $34.70, by gaining 1.34%. The 52 week range of $16.54-$35.92.Company’s market capitalization is $3.91 billion.
March 26, 2014 Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) , a developer and owner of casino gaming and entertainment resort facilities in Asia, has today unveiled the project details and architectural design of the fifth hotel tower at City of Dreams, the Company’s flagship property in Cotai targeting the premium segment. The Company is proud to announce its partnership with the award-winning, internationally renowned and highly praised “Queen of the Curve” in architecture, Dame Zaha Hadid on the design of the new hotel tower, which will add a truly iconic landmark to the Cotai skyline and the culturally rich city of Macau. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) stock is currently trading at $40.64 .The EPS of the stock is 1.15. Company’s market capitalization is $22.37 billion.
The Medicines Company (NASDAQ:MDCO) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company’s earnings per share and deteriorating net income.The Medicines Company (NASDAQ:MDCO) stock opened the session at $23.89, and now is at $24.20. The 52 week range of the MDCO stock remained $23.53-$41.28 and the day range was $23.53-$28.60.